Potential SARS-CoV-2 main protease inhibitors.
Potential SARS-CoV-2 main protease inhibitors.
复制标题
DOI:
10.1016/j.drudis.2020.12.005
复制
发表时间:
2021-03
影响因子:
7.4
通讯作者:
Tillekeratne LMV
中科院分区:
文献类型:
--
作者:
Banerjee R;Perera L;Tillekeratne LMV
The coronavirus disease 2019 (COVID-19) pandemic has prompted an urgent need for new treatment strategies. No target-specific drugs are currently available for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), but new drug candidates targeting the viral replication cycle are being explored. A prime target of drug-discovery efforts is the SARS-CoV-2 main protease (Mpro). The main proteases of different coronaviruses, including SARS-CoV-2, SARS-CoV and Middle East respiratory syndrome coronavirus (MERS-CoV), share a structurally conserved substrate-binding region that can be exploited to design new protease inhibitors. With the recent reporting of the X-ray crystal structure of the SARS-CoV-2 Mpro, studies to discover Mpro inhibitors using both virtual and in vitro screening are progressing rapidly. This review focusses on the recent developments in the search for small-molecule inhibitors targeting the SARS-CoV-2 Mpro.
登录
查看更多内容
影响因子:
5
作者:
Grum-Tokars, Valerie;Ratia, Kiira;Begaye, Adrian;Baker, Susan C.;Mesecar, Andrew D.
通讯作者:
Mesecar, Andrew D.
DOI:
10.1080/07391102.2020.1760137
发表时间:
2020-05-05
影响因子:
4.4
作者:
Joshi, Rakesh S.;Jagdale, Shounak S.;Kulkarni, Mahesh J.
通讯作者:
Kulkarni, Mahesh J.
影响因子:
3.1
作者:
Dong, Liying;Hu, Shasha;Gao, Jianjun
通讯作者:
Gao, Jianjun
DOI:
10.1080/07391102.2020.1782768
发表时间:
2020-06-23
影响因子:
4.4
作者:
Alamri, Mubarak A.;ul Qamar, Muhammad Tahir;Salo-Ahen, Outi M. H.
通讯作者:
Salo-Ahen, Outi M. H.
影响因子:
3.1
作者:
Jimenez-Alberto, Alicia;Maria Ribas-Aparicio, Rosa;Castelan-Vega, Juan A.
通讯作者:
Castelan-Vega, Juan A.